-->

Iklan Billboard 970x250

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine
»

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

Ajstyles
0
CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...
Baca Juga
SHARE
Subscribe to get free updates

Related Posts

Post a Comment

Post a Comment

Iklan Tengah Post